These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1126 related articles for article (PubMed ID: 17417046)

  • 1. Migration, mental health and costs consequences in Romania.
    Miclutia I; Junjan V; Popescu CA; Tigan S
    J Ment Health Policy Econ; 2007 Mar; 10(1):43-50. PubMed ID: 17417046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.
    Fleming E; Lien H; Ma CT; McGuire TG
    J Ment Health Policy Econ; 2003 Mar; 6(1):3-12. PubMed ID: 14578543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in use and costs of primary health and social services in mental health or drinking problems.
    Forma L; Jarvala T; Ahonen J; Vitikainen K; Rissanen P
    J Ment Health Policy Econ; 2009 Jun; 12(2):79-86. PubMed ID: 19567933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of nine common mental disorders: implications for curative and preventive psychiatry.
    Smit F; Cuijpers P; Oostenbrink J; Batelaan N; de Graaf R; Beekman A
    J Ment Health Policy Econ; 2006 Dec; 9(4):193-200. PubMed ID: 17200596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-outcome of anxiety treatment intervention in primary care in Hungary.
    Zámbori J; Szádóczky E; Rózsa S; Füredi J
    J Ment Health Policy Econ; 2002 Sep; 5(3):115-20. PubMed ID: 12728198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does co-morbid depression impact diabetes related costs? Evidence from a cross-sectional survey in a low-income country.
    Chereches RM; Litan CM; Zlati AM; Bloom JR
    J Ment Health Policy Econ; 2012 Sep; 15(3):127-38. PubMed ID: 23001281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bottom-up analysis of the case costs of stem cell transplantation and selected chemotherapies].
    Stäbler W; Wagner B
    Klin Padiatr; 2003; 215(3):179-84. PubMed ID: 12778360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of social services for the chronically mentally ill in a Polish mental health district: consequences for service use and costs.
    Zaluska M; Suchecka D; Traczewska Z; Paszko J
    J Ment Health Policy Econ; 2005 Mar; 8(1):37-44. PubMed ID: 15870484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. India mental health country profile.
    Khandelwal SK; Jhingan HP; Ramesh S; Gupta RK; Srivastava VK
    Int Rev Psychiatry; 2004; 16(1-2):126-41. PubMed ID: 15276945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing complex patients on a medical psychiatric unit: an observational study of university hospital costs associated with medical service use, length of stay, and psychiatric intervention.
    Leue C; Driessen G; Strik JJ; Drukker M; Stockbrügger RW; Kuijpers PM; Masclee AA; van Os J
    J Psychosom Res; 2010 Mar; 68(3):295-302. PubMed ID: 20159217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Admission decisions following contact with an emergency mental health assessment and intervention service.
    Brooker C; Ricketts T; Bennett S; Lemme F
    J Clin Nurs; 2007 Jul; 16(7):1313-22. PubMed ID: 17584350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Income and employment of people living with combined HIV/AIDS, chronic mental illness, and substance abuse disorders.
    Conover CJ; Arno P; Weaver M; Ang A; Ettner SL
    J Ment Health Policy Econ; 2006 Jun; 9(2):71-86. PubMed ID: 17007485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care resource use associated with integrated psychological treatment.
    Vasiliadis HM; Briand C; Lesage A; Reinharz D; Stip E; Nicole L; Lalonde P
    J Ment Health Policy Econ; 2006 Dec; 9(4):201-7. PubMed ID: 17200597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of mental health utilization and costs among children in a privately insured population.
    Leslie DL; Rosenheck RA; Horwitz SM
    Health Serv Res; 2001 Apr; 36(1 Pt 1):113-27. PubMed ID: 11324739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of the costs of treating schizophrenia in Spain: a hierarchical Bayesian approach.
    Vázquez-Polo FJ; Negrín M; Cabasés JM; Sánchez E; Haro JM; Salvador-Carulla L
    J Ment Health Policy Econ; 2005 Sep; 8(3):153-65. PubMed ID: 16278503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric care in restricted conditions for work migrants, refugees and asylum seekers: experience of the Open Clinic for Work Migrants and Refugees, Israel 2006.
    Lurie I
    Isr J Psychiatry Relat Sci; 2009; 46(3):172-81. PubMed ID: 20039517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
    Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
    J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.